Company news
Aptose Biosciences Inc news in 2014
Aptose Biosciences Inc's news releases, calls and decks from 2014, newest first.
Aptose Biosciences Announces Appointment of Dr. Erich Platzer to Board of Directors
December 15, 2014
Aptose Biosciences Presents APTO-253 Preclinical Data at 56th American Society of Hematology Annual Meeting
December 9, 2014
Aptose Biosciences to Present at Oppenheimer & Co. 25th Annual Healthcare Conference
December 5, 2014
Aptose Biosciences to Present Preclinical Research Update for APTO-253 at the 56th American Society of Hematology Annual Meeting
December 3, 2014
Aptose Biosciences to Present at The Stifel 2014 Healthcare Conference
November 17, 2014
Aptose Biosciences reports results for the four months ended September 30, 2014
November 4, 2014
Aptose Biosciences To Host Conference Call and Webcast For Four Month Interim Period Ended September 30, 2014
October 30, 2014
Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTO
October 21, 2014
Aptose Biosciences to Present at the 2014 BIO Investor Forum
October 3, 2014
Aptose Biosciences Announces Reverse Stock Split
October 1, 2014
Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & Science University
September 29, 2014
Aptose Biosciences to Present at Upcoming Investor Conferences
September 25, 2014
Aptose Biosciences Recruits Stephen B. Howell, M.D. to Act in the Capacity of Chief Medical Officer
September 8, 2014
Lorus Therapeutics Implements Name Change to Aptose Biosciences
September 2, 2014
Lorus Therapeutics Announces Results of Annual and Special Meeting of Shareholders
August 19, 2014
Lorus Therapeutics Proposes Name Change to "APTOSE BIOSCIENCES" and Share Consolidation for Potential NASDAQ Listing
July 15, 2014